Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 7, 2015
KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1
Minjing Zou, Essa Y Baitei, Roua A Al-Rijjal, et al.
Scientific Reports
|
June 4, 2024
An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy
Constantinos Demetriou, Naila Abid, Michael Butterworth, et al.
Communications Biology
|
September 22, 2023
BRAF<sup>V600E</sup>-mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism
Paulina Rzasa, Sarah Whelan, Pooyeh Farahmand, et al.
Nature Cell Biology
|
June 18, 2013
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Nature Cell Biology
|
April 28, 2026
Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Nature Communications
|
August 26, 2016
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma
Patrizia Cammareri, Aidan M Rose, David F Vincent, et al.
Nature Communications
|
June 8, 2021
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
Min Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications
|
March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
Min Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications
|
July 21, 2025
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial
Dean A Fennell, Kayleigh Hill, Min Zhang, et al.
Nature Communications
|
August 21, 2024
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma
Min Zhang, Aleksandra Bzura, Essa Y Baitei, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 7, 2015
KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1
Minjing Zou, Essa Y Baitei, Roua A Al-Rijjal, et al.
Scientific Reports
|
June 4, 2024
An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy
Constantinos Demetriou, Naila Abid, Michael Butterworth, et al.
Communications Biology
|
September 22, 2023
BRAF<sup>V600E</sup>-mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism
Paulina Rzasa, Sarah Whelan, Pooyeh Farahmand, et al.
Nature Cell Biology
|
June 18, 2013
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Nature Cell Biology
|
April 28, 2026
Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta, Ana Banito, Torsten Wuestefeld, et al.
Nature Communications
|
August 26, 2016
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma
Patrizia Cammareri, Aidan M Rose, David F Vincent, et al.
Nature Communications
|
June 8, 2021
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
Min Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications
|
March 20, 2021
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
Min Zhang, Jin-Li Luo, Qianqian Sun, et al.
Nature Communications
|
July 21, 2025
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial
Dean A Fennell, Kayleigh Hill, Min Zhang, et al.
Nature Communications
|
August 21, 2024
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma
Min Zhang, Aleksandra Bzura, Essa Y Baitei, et al.
Page
of 6